Table 9.
Top 20 references by burst strength (2015–2024).
| Begin | End | Strength | Year | Entity |
|---|---|---|---|---|
| 2015 | 2018 | 20.9663 | 2015 | Parker C, 2013, New Engl J Med, V369, P213, DOI 10.1056/NEJMoa1213755 |
| 2015 | 2016 | 17.4694 | 2015 | Lutz S, 2011, Int J Radiat Oncol, V79, P965, DOI 10.1016/j.ijrobp.2010.11.026 |
| 2015 | 2017 | 16.364 | 2015 | Chow E, 2012, Clin Oncol-UK, V24, P112, DOI 10.1016/j.clon.2011.11.004 |
| 2015 | 2016 | 14.6569 | 2015 | Fizazi K, 2011, Lancet, V377, P813, DOI 10.1016/S0140-6736(10)62344-6 |
| 2015 | 2017 | 9.288 | 2015 | Chow E, 2012, Int J Radiat Oncol, V82, P1730, DOI 10.1016/j.ijrobp.2011.02.008 |
| 2015 | 2018 | 7.9968 | 2015 | Callstrom MR, 2013, CANCER-AM CANCER SOC, V119, P1033, DOI 10.1002/cncr.27793 |
| 2016 | 2019 | 8.8281 | 2015 | Coleman R, 2014, Ann Oncol, V25, P124, DOI 10.1093/annonc/mdu103 |
| 2017 | 2019 | 10.0015 | 2015 | Chow E, 2014, Lancet Oncol, V15, P164, DOI 10.1016/S1470-2045(13)70556-4 |
| 2018 | 2022 | 11.8206 | 2017 | Lutz S, 2017, Pract Radiat Oncol, V7, P4, DOI 10.1016/j.prro.2016.08.001 |
| 2018 | 2021 | 10.8307 | 2016 | Saad F, 2016, Lancet Oncol, V17, P1306, DOI 10.1016/S1470-2045(16)30173-5 |
| 2019 | 2024 | 16.6916 | 2018 | Rich SE, 2018, Radiother Oncol, V126, P547, DOI 10.1016/j.radonc.2018.01.003 |
| 2019 | 2022 | 14.7728 | 2017 | Macedo F, 2017, Oncol Rev, V11, P43, DOI 10.4081/oncol.2017.321 |
| 2020 | 2024 | 11.1245 | 2018 | Fornetti J, 2018, J Bone Miner Res, V33, P2099, DOI 10.1002/jbmr.3618 |
| 2020 | 2024 | 8.649 | 2019 | Nguyen QN, 2019, JAMA Oncol, V5, P872, DOI 10.1001/jamaoncol.2019.0192 |
| 2021 | 2024 | 8.1085 | 2020 | Coleman R, 2020, Ann Oncol, V31, P1650, DOI 10.1016/j.annonc.2020.07.019 |
| 2022 | 2024 | 16.4974 | 2021 | Sahgal A, 2021, Lancet Oncol, V22, P1023, DOI 10.1016/S1470-2045(21)00196-0 |
| 2022 | 2024 | 15.3184 | 2021 | Sung H, 2021, CA-Cancer J Clin, V71, P209, DOI 10.3322/caac.21660 |
| 2022 | 2024 | 12.1953 | 2020 | Coleman RE, 2020, Nat Rev Dis Primers, V6, P0, DOI 10.1038/s41572-020-00216-3 |
| 2022 | 2024 | 9.1024 | 2021 | Pielkenrood BJ, 2021, Int J Radiat Oncol, V110, P358, DOI 10.1016/j.ijrobp.2020.11.060 |
| 2022 | 2024 | 8.6836 | 2018 | Sprave T, 2018, Radiother Oncol, V128, P274, DOI 10.1016/j.radonc.2018.04.030 |